Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
STAAR Surgical Company STAA
$62.19
-$2.08 (-3.34%)
На 18:00, 12 мая 2023
+10.15%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
3131991360.00000000
-
week52high
112.27
-
week52low
46.36
-
Revenue
284391000
-
P/E TTM
83
-
Beta
1.22837300
-
EPS
0.81000000
-
Last Dividend
0.00000000
-
Next Earnings Date
03 мая 2023 г. в 20:00
Описание компании
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Needham | Buy | Buy | 11 авг 2022 г. |
| Jefferies | Buy | Buy | 11 авг 2022 г. |
| Benchmark | Buy | Buy | 11 авг 2022 г. |
| Canaccord Genuity | Buy | Buy | 26 апр 2022 г. |
| Needham | Buy | 08 апр 2022 г. | |
| Canaccord Genuity | Buy | Buy | 14 окт 2022 г. |
| Mizuho | Buy | 13 окт 2022 г. | |
| Sidoti & Co. | Buy | Neutral | 07 ноя 2022 г. |
| Needham | Buy | Buy | 03 ноя 2022 г. |
| BTIG | Buy | Buy | 03 ноя 2022 г. |
| Stifel | Hold | 08 дек 2022 г. | |
| Stephens & Co. | Overweight | Overweight | 28 дек 2022 г. |
| Benchmark | Buy | Buy | 01 февр 2023 г. |
| Canaccord Genuity | Buy | Buy | 30 янв 2023 г. |
| Canaccord Genuity | Buy | Buy | 20 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| FRINZI THOMAS G | A | 160638 | 160638 | 03 янв 2023 г. |
| FRINZI THOMAS G | A | 92534 | 87805 | 03 янв 2023 г. |
| Francese James E | A | 19139 | 19139 | 30 дек 2022 г. |
| BROADWOOD PARTNERS, L.P. | A | 8783082 | 0 | 29 дек 2022 г. |
| BROADWOOD PARTNERS, L.P. | A | 8743992 | 0 | 28 дек 2022 г. |
| BROADWOOD PARTNERS, L.P. | A | 8643992 | 0 | 27 дек 2022 г. |
| Francese James E | D | 0 | 13075 | 27 сент 2022 г. |
| Francese James E | D | 34908 | 13075 | 27 сент 2022 г. |
| Francese James E | A | 47983 | 13075 | 27 сент 2022 г. |
| Francese James E | D | 50591 | 6667 | 27 сент 2022 г. |
Новостная лента
STAAR Surgical Company (STAA) Q1 2023 Earnings Call Transcript
Seeking Alpha
03 мая 2023 г. в 22:51
STAAR Surgical Company (NASDAQ:STAA ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Brian Moore - VP of Investor, Media Relations and Corporate Development Tom Frinzi - President and CEO Patrick Williams - CFO Conference Call Participants Anthony Petrone - Mizuho Group Margaret Kaczor - William Blair Samuel Durno - BTIG John Young - Canaccord Yang Li - Jefferies David Saxon - Needham Ron Feiner - Oppenheimer Harrison Parsons - Stephens Inc. Tom Stephan - Stifel Jim Sidoti - Sidoti & Company Bruce Jackson - Benchmark Company Operator Good day, ladies and gentlemen. Thank you for standing by.
STAAR Surgical Company (STAA) Q4 2022 Earnings Call Transcript
Seeking Alpha
21 февр 2023 г. в 23:13
STAAR Surgical Company (NASDAQ:STAA ) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Brian Moore - Vice President of Investor, Media Relations & Corporate Development Tom Frinzi - President, Chief Executive Officer & Chairman Patrick Williams - Chief Financial Officer Conference Call Participants Margaret Kaczor - William Blair Anthony Petrone - Mizuho Zach Weiner - Jefferies David Saxon - Needham Thomas Stephan - Stifel Ryan Zimmerman - BTIG Operator Good day ladies and gentlemen. Thank you for standing by.
Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates
Zacks Investment Research
21 февр 2023 г. в 18:49
Staar Surgical (STAA) delivered earnings and revenue surprises of -6.67% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
STAAR Surgical (STAA) to Report Q4 Earnings: What's in Store?
Zacks Investment Research
03 февр 2023 г. в 15:03
Strong growth in EVO ICL units led by increased market adoption is likely to have driven STAAR Surgical's (STAA) Q4 revenues.
STAAR Surgical Company (STAA) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
03 февр 2023 г. в 10:32
Zacks.com users have recently been watching Staar Surgical (STAA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.